NanoSyrinx
A highly experienced CBO, Jane brings a wealth of knowledge about business development and driving company growth, particularly for platform biotech companies. She serves on the boards of Spirea, PharmEnable, Macomics and is the Chair of the Sir Richard Stapley Educational Trust. With over 30 years in biotech and pharma business development, her past roles include Chief Business Officer at F-star, Vice President of Business Development at Cellzome, and Director of Business Development at MedImmune (formerly Cambridge Antibody Technologies).
Jane holds an MA and PhD in Natural Sciences from Cambridge University, as well as an MBA from the Cambridge Judge Business School.
This person is not in the org chart
This person is not in any teams
This person is not in any offices
NanoSyrinx
NanoSyrinx is a cutting-edge synthetic biology company creating the next generation of targeted drug delivery systems to address challenges in the biologic delivery sector.